Cardiovascular Systems (CSII) Misses Q3 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Leerink Partners Raises Price Target as Cardiovascular Systems (CSII) Reports Above Preannouncement
May 5, 2016 8:52 AM EDTLeerink Partners reiterated a Market Perform rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $15.00 (from $13.00), following the company's 3Q earnings report. CSII reported sales of $44.5M, slightly above its preannounced range of $43.5M-$44M. Leerink continues to view CSII's longterm... More
Cardiovascular Systems (CSII) Offers Three-Year Data from Pivotal ORBIT II Study
May 5, 2016 8:08 AM EDTCardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
The ORBIT II study evaluated the safety and efficacy of the companys Diamondback 360® Coronary Orbital Atherectomy System... More
